| Product NDC: | 65862-099 |
| Proprietary Name: | Cefprozil |
| Non Proprietary Name: | Cefprozil |
| Active Ingredient(s): | 125 mg/5mL & nbsp; Cefprozil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65862-099 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065381 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070130 |
| Package NDC: | 65862-099-50 |
| Package Description: | 50 mL in 1 BOTTLE (65862-099-50) |
| NDC Code | 65862-099-50 |
| Proprietary Name | Cefprozil |
| Package Description | 50 mL in 1 BOTTLE (65862-099-50) |
| Product NDC | 65862-099 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cefprozil |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20070130 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | CEFPROZIL |
| Strength Number | 125 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes |